Patient Management

	Patient Eligibility Criteria for Eligibility for the LAP-BAND^® System		Insurance and Costs Information on Cost of Surgery, Insurance Coverage, and Reimbursement
	Patient Education Material Links and Resources for your Patient		Patient Support Resources Post-operative Patient Monitoring and Support
	Risk Information LAP-BAND^® System Risk Information

Reference

National Heart, Lung, and Blood Institute Web site. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. Available at: http://www.nhlbi.nih.gov/guidelines/obesity/prctgd_c.pdf. Accessed March 27, 2009.

Chaston TB, Dixon JB, O'Brien PE. Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes 2007;31:743-750.

Dávila-Cervantes A, Borunda D, Domínguez-Cherit G, et al. Open Versus Laparoscopic Vertical Banded Gastroplasty: A Randomized Controlled Double Blind Trial. Obes Surg 2002;12:812-818.

Sears D, Fillmore G, Bui M, et al. Evaluation of Gastric Bypass Patients 1 Year After Surgery: Changes in Quality of Life and Obesity-Related Conditions. Obes Surg 2008;18:1522-1525.

Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient. Surg Obes Relat Dis 2008;4:S109-184.

Data on File. Allergan, Inc. Irvine, CA. November , 2010.

Directions For Use (DFU). LAP-BAND AP^® Adjustable Gastric Banding System with OMNIFORM^® Design. Allergan, Inc. Irvine, CA. 02/11. The LAP-BAND^® System was approved in the United States on the basis of a nonrandomized, single-arm study (N=299). Significant improvement in percent of excess weight loss vs. baseline was achieved at 12 months (34.5%), 24 months (37.8%), and 36 months (36.2%).

LAP-BAND^® Adjustable Gastric Banding System P000008/S017. Gastroenterology and Urology Devices Panel, Food and Drug Administration. Accessed March 25, 2011 at: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/Gastroenterology-UrologyDevicesPanel/UCM237422.ppt.

O'Brien PE, McPhail T, Chaston TB, et al. Systematic review of medium-term weight loss after bariatric operations. Obes Surg 2006;16:1032-1040.

American Society of Metabolic and Bariatric Surgery Clinical Issues Committee Web site. ASMBS position statement on sleeve gastrectomy as a bariatric procedure.Approved by the ASMBS Executive Council June 2007. Available at: http://www.pugetsoundsurgicalcenter.com/sleeve_statement.pdf. Accessed June 3, 2009.

10.

Chapman A, Game P, O'Brien P. Laparoscopic adjustable gastric banding for the treatment of obesity: update and re-appraisal. ASERNIP-S Report No.31, Second Edition. Adelaide, South Australia. ASERNIP-S, June 2002.

11.

The Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative Safety in the Longitudinal Assessment of Bariatric Surgery. New Eng J Med 2009;361(5)445-454.

12.

Lalor PF, Tucker O, Szomstein S, Rosenthal RJ. Complications after laparoscopic sleeve gastrectomy. Surge Obes Relat Dis. 2008;4:33-38.

13.

LAP-BAND^® Adjustable Gastric Banding System [directions for use]. Irvine, CA:Allergan, Inc, 2008.

14.

Fisher B, Schauer P. Medical and surgical options in the treatment of severe obesity. Am J Surg. 2002; 184:9S-16S.

15.

Ferraro DR. Management of the bariatric surgery patient. Clin Rev. 2004;14:73-79.

16.

Aggarwal S, Kini SU, Herron DM. Laparoscopic sleeve gastrectomy for morbid obesity: a review. Surg Obes Relat Dis. 2007;3:189-194.

17.

Elder KA and Wolfe BM. Bariatric Surgery: A Review of Procedures and Outcomes. Gastroent 2007;132:2253-2271.

18.

Spivak H, Hewitt MF, Onn A, Half EE. Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure. Am J Surg 2005;189:27-32.

19.

Ahroni JH, Montgomery KF, Watkins BM. Laparoscopic adjustable gastric banding: weight loss, co-morbidities, medication usage and quality of life at one year. Obes Surg 2005;15:641-647.

20.

Kleinman NL, Melkonian A, Borden S, et al. The Impace of Morbid Obesity and Bariatric Surgery on Comorbid Conditions: A Comprehensive Examination of Comorbidities in an Employed Population. JOEM 2009;51(2)170-179.

21.

Brancatisano A, Wahlroos S, Brancatisano R. Improvement in comorbid illness after placement of the Swedish Adjustable Gastric Band. Surg Obes Relat Dis 2008;4:S39-46.

22.

Dixon J, O’Brien P. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 2002;184:S51-4.

23.

Korenkov M, Shah S, Sauerland S, et al. Impact of Laparoscopic Adjustable Gastric Banding on Obesity Co-morbidities in the Medium- and Long-Term. Obes Surg 2007;17:679-83.

24.

Data on file, Allergan, Inc. June 2010.

25.

Ponce J, Paynter S, Fromm R. Laparoscopic adjustable gastric banding: 1,014 consecutive cases. J Am Coll Surg 2005;201:529-535.

26.

Dixon JB, Chapman L, O'Brien P. Marked improvement in asthma after LAP-BAND^® surgery for morbid obesity. Obes Surg 1999;9:385-389.

27.

Dixon JB, O'Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002;25(2)358-363.

28.

Dixon JB, Schachter LM, O'Brien PE. Sleep disturbance and obesity: changes following surgically induced weight loss. Arch Intern Med 2001;161:102-106.

29.

Dixon JB, O'Brien PE. Gastroesophageal reflux in obesity: the effect of Lap-Band placement. Obes Surg 1999;9:527-531.

30.

Sugerman HJ. The pathophysiology of severe obesity and the effects of surgically induced weight loss. Surg Obes Relat Dis 2005;109-119.

31.

Kuruba R, Almahmeed T, Martinez F, et al. Bariatric surgery improves urinary incontinence in morbidly obese individuals. Surg Obes Relat Dis 2007;3:586-90.

32.

Burgio K, Richter H, Clements R, et al. Chances in urinary and fecal incontinence symptoms with weight loss surgery in morbidly obese women. Obstet Gynecol 2007;110:1034-40.

33.

Laungani R, Seleno N, Carlin A. Effect of laparoscopic gastric bypass surgery on urinary incontinence in morbidly obese women. Surg Obes Relat Dis 2009;5:334-8.

34.

Kim T, Daud A, Ude O, et al. Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc 2006;20:202-9.

35.

Sugerman HJ, Sugerman EL, Wolfe L, et al. Risks and Benefits of Gastric Bypass in Morbidly Obese Patients With Severe Venous Stasis Disease. Ann Surg 2001;234(1)41-46.

36.

Dixon J, Dixon M, O’Brien P. Quality of life after lap-band placement: influence of time, weight loss, and comorbidities. Obes Res 2001;9:713-21.

37.

Parikh MS, Laker S, Weiner M, et al. Objective Comparison of Complications Resulting from Laparoscopic Bariatric Procedures. J Am Coll Surg 2006; 202(2)252-261.

38.

Chapman AE, Kiroff G, Game P, et al. Laparoscopic adjustable gastric bading in the treatment of obesity: A systematic literature review. Surg. 2004. 135:3:326-351.

39.

O'Brien PE, Dixon JB. Weight loss and early and late complications – the international experience. Am J Surg. 2002; 184:42S-45S.

40.

O'Brien PE, Dixon JB, Brown W, et al. The laparoscopic adjustable gastric band (Lap-Band^®): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg. 2002;12:652-660.

41.

Maniscalco M, Zedda A, Faraone S, et al. Weight loss and asthma control in severely obese asthmatic females. Resp Med 2008;102:102-8.

42.

Ponce J, Haynes B, Paynter S, et al. Effect of LAP-BAND® Induced Weight Loss on Type 2 Diabetes Mellitus and Hypertension. Obes Surg 2004:14:1335-1342.

43.

Buchwald H, Avidor Y, Braunwald E, et al. Bariatric Surgery: A Systematic Review and Meta-analysis. JAMA 2004;292:1724-37.

44.

Taylor CJ, Layani L. Laparoscopic Adjustable Gastric Banding in Patients >=60 Years Old: Is it Worthwhile?. Obes Surg 2006:16:1579-1583.

45.

Edwards MA, Grinbaum R, Schneider BE, et al. Benchmarking hospital outcomes for laparoscopic adjustable gastric banding. Surg Endosc 2007:21:1950-1956.

46.

Frigg A, Peterli, R, Peters T, et al. Reduction in Co-morbidities 4 Years after Laparoscopic Adjustable Gastric Banding. Obes Surg 2004:14:216-223.

47.

Pontiroli AE, Folli F, Paganelli N, et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity – A 4-year case-controlled study. Diab Care 2005;28(11)2703-2709.

48.

Shen R, Dugay G, Rajaram K, et al. Impact of Patient Follow-up on Weight Loss after Bariatric Surgery. Obes Surg 2004;14:514-519.

49.

Singhal R, Kitchen M, Bridgwater S, et al. Metabolic Outcomes of Obese Diabetic Patients Following Laparoscopic Adjustable Gastric Banding. Obes Surg 2008:18:1400-1405.

50.

Cunneen SA, Phillips E, Fielding G, et al. Studies of Swedish adjustable gastric band and Lap-Band: systematic review and meta-analysis. Surg Obes Relat Dis 2008;4:174-185.

51.

Spanakis E, Gragnoli C. Bariatric Surgery, Safety and Type 2 Diabetes. Obes Surg 2009;19:363-368.

52.

Centers for Disease Control and Prevention Web site. Sleep and Sleep Disorders. Available at: http://www.cdc.gov/sleep/disorders.htm. Accessed April 2, 2009.

53.

Das SK and Farooqi A. Osteoarthritis. Best Prac & Rsch Clin Rheumat 2008;22(4)657-675.

54.

Cunneen S. Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable gastric banding. Surg Obes Relat Dis 2008;4:S47-55.

55.

Brancatisano A, Wahlroos S, Matthews S, Brancatisano R. Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese. Surg Obes Relat Dis 2008;4:423-9.

56.

Mittermair R, Weiss H, Nehoda H, et al. Laparoscopic Swedish adjustable gastric banding: 6-year follow-up and comparison to other laparoscopic bariatric procedures. Obes Surg 2003;13:412-7.

57.

Brancatisano A, Wahlroos S, Brancatisano R. Improvement in comorbid illness after placement of the Swedish Adjustable Gastric Band. Surg Obes Relat Dis 2008;4:S39-46.

58.

Pontiroli AE, Folli F, Paganelli M, et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care 2005;28(11):2703–9.

59.

Dixon JB, Dixon ME, O'Brien PE. Pregnancy after Lap-Band(R) Surgery: Management of the Band to Achieve Healthy Weight Outcomes. Obes Surg 2008:11:59-65.

60.

Martin LF, Finigan KM, Nolan TE. Pregnancy After Adjustable Gastric Banding. Obstet Gynecol 2000;95(6):927-930.

61.

Weiss HG, Nehoda H, Labeck B, et al. Pregnancies after Adjustable Gastric Banding. Obes Surg 2008:11:303-306.

62.

Kral JG, Biron, S, Simard S, et al. Large Maternal Weight Loss From Obesity Surgery Prevents Transmission of Obesity to Children Who Were Followed for 2 to 18 Years. Pediatrics. 2006. 118:e1644-e1649.

63.

Melissas J, Kontakis G, Volakakis E, et al. The Effect of Surgical Weight Reduction on Functional Status in Morbidly Obese Patients with Low Back Pain. Obes Surg 2005;15:378-81.

64.

Phelan S, Wadden TA, Berkowitz RI, et al. Impact of weight loss on the metabolic syndrome. Int J Obes 2007;31:1442-1448.

65.

Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and morality in a prospective cohort of US adults. New Eng J Med 1999;341(15)1097-1105.

66.

Favretti F, Segato G, Ashton D, et al. Laparoscopic Adjustable Gastric Banding in 1,791 Consecutive Obese Patients: 12-Year Results. Obes Surg 2007;17:168-175.

67.

Christou N, Sampalis J, Lieberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004;240:416-23.

68.

Adams T, Gress R, Smith S, et al. Long-term mortality after gastric bypass surgery. New Eng J Med 2007;357:753–61.

69.

Sjostrom C, Lissner L, Wedel H, Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study.Obes Res 1999;7:477-84.

70.

Ahmed MH and Byrne CD. Current treatment of non-alcoholic fatty liver disease. Diab Obes & Metab 2009;11:188-195.

71.

Lee WJ, Wang W, Wei PL, et al. Weight Loss and Improvement of Obesity-related Illness Following Laparoscopic Adjustable Gastric Banding Procedure for Morbidly Obese Patients in Taiwan. J Fomos Med Assoc. 2006;105(11):887-94.

Reference

This content requires Flash. To download Flash click here.